Infection Drives IL-17-Mediated Neutrophilic Allergic Airways Disease

English version České info

A subset of patients with stable asthma has prominent neutrophilic and reduced eosinophilic inflammation, which is associated with attenuated airways hyper-responsiveness (AHR). Haemophilus influenzae has been isolated from the airways of neutrophilic asthmatics; however, the nature of the association between infection and the development of neutrophilic asthma is not understood. Our aim was to investigate the effects of H. influenzae respiratory infection on the development of hallmark features of asthma in a mouse model of allergic airways disease (AAD). BALB/c mice were intraperitoneally sensitized to ovalbumin (OVA) and intranasally challenged with OVA 12–15 days later to induce AAD. Mice were infected with non-typeable H. influenzae during or 10 days after sensitization, and the effects of infection on the development of key features of AAD were assessed on day 16. T-helper 17 cells were enumerated by fluorescent-activated cell sorting and depleted with anti-IL-17 neutralizing antibody. We show that infection in AAD significantly reduced eosinophilic inflammation, OVA-induced IL-5, IL-13 and IFN-γ responses and AHR; however, infection increased airway neutrophil influx in response to OVA challenge. Augmented neutrophilic inflammation correlated with increased IL-17 responses and IL-17 expressing macrophages and neutrophils (early, innate) and T lymphocytes (late, adaptive) in the lung. Significantly, depletion of IL-17 completely abrogated infection-induced neutrophilic inflammation during AAD. In conclusion, H. influenzae infection synergizes with AAD to induce Th17 immune responses that drive the development of neutrophilic and suppress eosinophilic inflammation during AAD. This results in a phenotype that is similar to neutrophilic asthma. Infection-induced neutrophilic inflammation in AAD is mediated by IL-17 responses.

Vyšlo v časopise: Infection Drives IL-17-Mediated Neutrophilic Allergic Airways Disease. PLoS Pathog 7(10): e32767. doi:10.1371/journal.ppat.1002244
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002244

Souhrn

Zdroje

1. UmetsuDTMcIntireJJAkbariOMacaubasCDeKruyffRH 2002 Asthma: an epidemic of dysregulated immunity. Nat Immunol 3 715 720

2. BusseWWLemanskeRF 2001 Asthma. New Engl J Med 344 350 362

3. DouwesJGibsonPPekkanenJPearceN 2002 Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57 643 648

4. GibsonPGSimpsonJLSaltosN 2001 Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119 1329 1336

5. PavordIDBrightlingCEWoltmannGWardlawAJ 1999 Non-eosinophilic corticosteroid unresponsive asthma. Lancet 353 2213 2214

6. WenzelSESchwartzLBLangmackELHallidayJLTrudeauJB 1999 Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Resp Crit Care 160 1001 1008

7. GodonPBouletLPMaloJLCartierALemiereC 2002 Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids. Eur Respir J 20 1364 1369

8. SimpsonJLScottRBoyleMJGibsonPG 2006 Inflammatory subtypes in asthma: Assessment and identification using induced sputum. Respirology 11 54 61

9. AdcockIMItoK 2004 Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue? Curr Opin Pharmacol 4 257 262

10. GreenRHBrightlingCEWoltmannGParkerDWardlawAJ 2002 Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57 875 879

11. BerryMMorganAShawDEParkerDGreenR 2007 Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 62 1043 1049

12. SimpsonJLGrissellTVDouwesJScottRJBoyleMJ 2007 Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 62 211 218

13. MoletSHamidQDavoinebFNutkuETahaaR 2001 IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 108 430 438

14. StefanoADCaramoriGGnemmiIContoliMVicariC 2009 T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol 157 316 324

15. BullensDTruyenECoteurLDilissenEHellingsP 2006 IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 7 135 143

16. HansbroPMKaikoGEFosterPS 2011 Cytokine/anti-cytokine therapy - novel treatments for asthma? Brit J Pharmacol 163 81 95

17. LeipeJGrunkeMDechantCReindlCKerzendorfU 2010 Th17 cells in autoimmune arthritis. Ann Rheum Dis 69 A69 A70

18. JiYYiweiCXueYDiGLubingZ 2009 Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 60 1472 1483

19. HaradaASekidoNAkahoshiTWadaTMukaidaN 1994 Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukocyte Biol 56 559 564

20. PellmeSMorgelinMTapperHMellqvistU-HDahlgrenC 2006 Localization of human neutrophil interleukin-8 (CXCL-8) to organelle(s) distinct from the classical granules and secretory vesicles. J Leukocyte Biol 79 564 573

21. HellingsPWKasranALiuZVandekerckhovePWuytsA 2003 Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Resp Cell Mol 28 42 50

22. LangrishCLChenYBlumenscheinWMMattsonJBashamB 2005 IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 233 240

23. LiangSCLongAJBennettFWhittersMJKarimR 2007 An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 179 7791 7799

24. LockhartEGreenAMFlynnJL 2006 IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177 4662 4669

25. RoarkCLSimonianPLFontenotAPBornWKO'BrienRL 2008 γδ T cells: an important source of IL-17. Curr Opin Immunol 20 353 357

26. FerrettiSBonneauODuboisGRJonesCETrifilieffA 2003 IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 170 2106 2112

27. SongCLuoLLeiZLiBLiangZ 2008 IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 181 6117 6124

28. ZhouQDestaTFentonMGravesDTAmarS 2005 Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA Protein. Infect Immun 73 935 943

29. YePRodriguezFHKanalySStockingKLSchurrJ 2001 Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194 519 528

30. FeinenBGaffenSLJerseAERussellMW 2009 IL-17 elicits a neutrophil-attractant response to Neisseria gonorrhoeae infection. J Immunol 182 38.25

31. ScurlockAMO'ConnellCMAndrewsCWFooteIPDarvilleTM 2009 Mucosal T-helper 17 responses to Chlamydia genital tract infection. J Allergy Clin Immun 123 S138 S138

32. WuQMartinRJRinoJGBreedRTorresRM 2007 IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect 9 78 86

33. WoodLGSimpsonJLHansbroPMGibsonPG 2010 Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia. Free Radical Res 44 146 154

34. ErwinALSmithAL 2007 Nontypeable Haemophilus influenzae: understanding virulence and commensal behaviour. Trends Microbiol 15 355 362

35. MurphyTF 2003 Respiratory infections caused by non-typeable Haemophilus influenzae. Curr Opin Infect Dis 16 129 134

36. MurphyTFBrauerALSchiffmacherATSethiS 2004 Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Resp Crit Care 170 266 272

37. AngrillJAgustiCde CelisRRanoAGonzalezJ 2002 Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 57 15 19

38. BarnesPJ 2002 New treatments for COPD. Nat Rev Drug Discov 1 437 446

39. WilsonR 2000 Evidence of bacterial infection in acute exacerbations of chronic bronchitis. Semin Respir Infect 15 208 215

40. LookDCChinCLManzelLJLehmanEEHumlicekAL 2006 Modulation of airway inflammation by Haemophilus influenzae isolates associated with chronic obstructive pulmonary disease exacerbation. Proc Am Thorac Soc 3 482 483

41. SeroogyCMGernJE 2005 The role of T regulatory cells in asthma. J Allergy Clin Immun 116 996 999

42. JakubzickCTackeFLlodraJvan RooijenNRandolphGJ 2006 Modulation of dendritic cell trafficking to and from the airways. J Immunol 176 3578 3584

43. BoytonRJ 2008 Bronchiectasis. Medicine 36 315 320

44. WarkPABJohnstonSLMoricISimpsonJLHensleyMJ 2001 Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 19 68 75

45. SamuelLFWilliamWB 2005 The role of rhinovirus in asthma exacerbations. J Allergy Clin Immun 116 267 273

46. FahyJVKimKWLiuJBousheyHA 1995 Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immun 95 843 852

47. HorvatJCStarkeyMRKimRYBeagleyKWPrestonJA 2010 Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease. J Immunol 184 4159 4169

48. ChoYSKimTBLeeTHMoonKALeeJ 2005 Chlamydia pneumoniae infection enhances cellular proliferation and reduces steroid responsiveness of human peripheral blood mononuclear cells via a tumor necrosis factor-alpha-dependent pathway. Clin Exp Allergy 35 1625 1631

49. WangFHeXYBainesKJGunawardhanaLPSimpsonJL 2011 Different inflammatory phenotypes in adults and children with acute asthma. Eur Respir J 38 567 574

50. PatelKKVicencioAGDuZTsirilakisKSalvaPS 2010 Infectious Chlamydia pneumoniae is associated with elevated interleukin-8 and airway neutrophilia in children with refractory asthma. Pediatr Infect Dis J 29 1093 1098

51. PrestonJAThorburnANStarkeyMRBeckettELHorvatJC 2010 Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T cells. Eur Respir J 37 1 12

52. ThorburnANO'SullivanBJRanjenyTKumarRKFosterPS 2010 Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease. Thorax 65 1053 1060

53. DongLLiHWangSLiY 2009 Different doses of lipopolysaccharides regulate the lung inflammation of asthmatic mice via TLR4 pathway in alveolar macrophages. J Asthma 46 229 233

54. EisenbarthSCPiggottDAHuleattJWVisintinIHerrickCA 2002 Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196 1645 1651

55. Delayre-OrthezCBeckerJde BlayFFrossardNPonsF 2005 Exposure to endotoxins during sensitization prevents further endotoxin-induced exacerbation of airway inflammation in a mouse model of allergic asthma. Int Arch Allergy Imm 138 298 304

56. RodriguezDKellerACFaquim-MauroELde MacedoMSCunhaFQ 2003 Bacterial lipopolysaccharide signaling through toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol 171 1001 1008

57. KimY-KOhS-YJeonSGParkH-WLeeS-Y 2007 Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol 178 5375 5382

58. LiJJWangWBainesKJBowdenNAHansbroPM 2010 IL-27/IFN-γ induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages. J Immunol 185 4401 4409

59. IngallsRRicePQureshiNTakayamaKLinJ 1995 The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 63 3125 3130

60. KlineJNKitagakiKBusingaTRJainVV 2002 Treatment of established asthma in a murine model using CpG oligodeoxynucleotides. Am J Physiol Lung Cell Mol Physiol 283 L170 L179

61. FonsecaDEKlineJN 2009 Use of CpG oligonucleotides in treatment of asthma and allergic disease. Adv Drug Delivery Rev 61 256 262

62. SerebriskyDTeperAAHuangC-KLeeS-YZhangT-F 2000 CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma. J Immunol 165 5906 5912

63. WakashinHHiroseKMaezawaYKagamiS-JSutoA 2008 IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Resp Crit Care 178 1023 1032

64. Schnyder-CandrianSTogbeDCouillinIMercierIBrombacherF 2006 Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 203 2715 2725

65. ParkSJLeeKSKimSRMinKHChoeYH 2009 Peroxisome proliferator-activated receptor γ agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation. J Immunol 183 3259 3267

66. CosmiLMaggiLSantarlasciVCaponeMCardilicchiaE 2010 Identification of a novel subset of human circulating memory CD4+ T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 125 222 230

67. HorvatJCBeagleyKWWadeMAPrestonJAHansbroNG 2007 Neonatal Chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Resp Crit Care 176 556 564

68. PrestonJAEssilfieA-THorvatJCWadeMABeagleyKW 2007 Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae. Vaccine 25 8154 8162

69. HorvatJCStarkeyMRKimRYPhippsSGibsonPG 2010 Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J Allergy Clin Immunol 125 617 625.e616

70. TakatoriHKannoYWatfordWTTatoCMWeissG 2009 Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206 35 41